cbd
Medspresso Joins the Speciality Coffee Association of South Africa
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / February 28, 2022 / WUHAN GENERAL GROUP, INC. (WUHN) (“WGG” or the “Company”), a bioceutical company focused on alternative plant-based cannabinoids and mental health therapeutic research is pleased to share the following update: Medspresso™ is pleased to announce its membership in the Speciality Coffee Association of South Africa (SCASA). SCASA is a […]
Grapefruit USA, Inc. Announces Term Sheet with Dubai-Based Lender to Build GPFT ‘Mothership’
LOS ANGELES and DESERT HOT SPRINGS, Calif., Feb. 16, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based canna-biotech company, announces today that the Company has executed a term sheet with the Al Habtoor Group, located in Dubai, United Arab Emirates, to finance development of […]
DENVER, CO, Feb. 16, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – CBD Global Sciences, Inc. (OTC: CBDNF) (CSE: CBDN) (Frankfurt:GS3), “CBD Global” or the “Company”), is pleased to announce the successful launch of Rap Snacks in the Colorado market that exceeded first week sales expectations. Within the first week of sales to the first few hundred of […]
INDIVA Launches New Cannabis Edible Formulated For Night-Time Use
New Wana Quick Midnight Berry Indica gummies offer a unique formulation of CBN, CBD, THC, and a proprietary terpene blend recommended for night-time use LONDON, ON, Feb. 15, 2022 /CNW/ – Indiva Limited (the “Company” or “Indiva“) (TSXV: NDVA) (OTCQX: NDVAF), a leading Canadian producer of cannabis edibles and other cannabis products, is taking an even bigger […]
BRAINS Bioceutical Initiates Clinical Trial Agreement To Tackle Opiod Addiction
The approved investigational new drug (IND) study is for a PK study to use as a precursor in an Opiate addiction study VANCOUVER, ON | FEBRUARY 9, 2022 — Brains Bioceutical Corp (“Brains Bio” or the “Company”), a global leader in pharmaceutical EU-GMP grade Cannabidiol (CBD) Active Pharmaceutical Ingredient (API), is pleased to announce the initiation […]
Brains Bio signs deal for landmark clinical trial to tackle opioid addiction
The approved investigational new drug (IND) study is for a PK study to use as a precursor in anOpiate addiction study VANCOUVER, BC, Feb. 9, 2022 /PRNewswire/ – Brains Bioceutical Corp (“Brains Bio” or the “Company”), a global leader in pharmaceutical EU-GMP grade Cannabidiol (CBD) Active Pharmaceutical Ingredient (API), is pleased to announce the initiation of […]
Vancouver, British Columbia–(Newsfile Corp. – February 3, 2022) – Harvest One Cannabis Inc. (TSXV: HVT) (OTCQX: HRVOF) (“Harvest One” or the “Company“), announced today the launch of its new LivRelief InfusedTM product SKU, Extra Strength Transdermal CBD Cream. This new SKU will be available at the Ontario Cannabis Store (“OCS“) as part of the Company’s brand expansion […]
Anticipates a 55% Increase Year-Over-Year Quarterly Revenue in 2022 PHOENIX, AZ, Feb. 02, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — American Green, Inc. (OTC:ERBB) announced today that revenue for its second fiscal quarter ended December 31, 2021, will be $515,000. This represents an increase of over 20% compared to the prior fiscal quarter ended December 31, 2020, at the […]
OMID Provides Fourth-Quarter and Year-End Financial Highlights
Phillipsburg, NJ, Feb. 01, 2022 (GLOBE NEWSWIRE) — Today, OMID Holdings, Inc. (OTC Pink: OMID) is pleased to share the results of an initial financial review of its fourth-quarter operations. The Unaudited Key Financial Highlights are provided below for the Fourth Quarter as well as the Year which ended on December 31, 2021. Operating […]
Audacious Firing on all Cylinders
LAS VEGAS, Jan. 26, 2022 /PRNewswire/ – Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA“, “AUDACIOUS” or the “Company“) is pleased to provide the following corporate update: Australis Capital Inc. logo (CNW Group/Australis Capital Inc.) “We are executing both within the U.S. and internationally, rapidly expanding our footprint, brand recognition and product offerings, while developing new […]
TORONTO, January 18, 2022–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), today announced that Endocanna Health (“Endocanna”), a company in which Heritage holds a 30% non-controlling interest, has entered into a strategic partnership with OMNI Medical Services (“OMNI”). OMNI is a multi-state operator of medical cannabis clinics, evaluations, research, pain […]
Xebra Granted Trademarks in the European Union
VANCOUVER, BC, Jan. 18, 2022 /PRNewswire/ – Xebra Brands Ltd. (“Xebra”) (CSE: XBRA) (OTCQB: XBRAF) (FSE: 9YC), a cannabis company, is pleased to announce that it has been granted trademarks in the European Union, covering 28 countries and 10 territories, for Xebra’s THC and CBD infused beverage brands, including MADCAP soft drinks, and the slogan Crazy Good, HOLAHI iced teas and the slogan It’s High […]
Yooma Wellness Announces Launch of MYO Plant Nutrition in Boots Stores Across the UK
Products will be available in up to 838 stores across the UK Toronto, Ontario, Canada, Jan. 17, 2022 (GLOBE NEWSWIRE) — Yooma Wellness Inc. (“Yooma“) (CSE: YOOM, AQSE: YOOM), a Toronto-based vertically-integrated global wellness platform that develops and markets a portfolio of CBD and wellness brands, is pleased to announce that Boots, one of the […]
Self-Affirmed GRAS status and recent regulatory achievements position HempFusion to meet or exceed US & global standards for CBD products DENVER, January 12, 2022–(BUSINESS WIRE)–HempFusion Wellness Inc. (TSX:CBD.U) (OTCQB:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness Company offering premium probiotic supplements and products containing CBD, announces that its exclusive and proprietary hemp-derived […]
NutraLife Accelerates Expansion into the Rapidly Growing $11 Billion CBD Industry
CBD has become one of the fastest-growing wellness products globally, reaching more than $11 billion in global sales last year. According to Market Data Forecast, these sales will continue to grow at a 22.2% annual pace to nearly $31 billion by 2026. As a result, companies building an early presence in the industry could be […]
How to Capitalize on Europe’s Exploding CBD Market
Europe is the second-largest CBD market in the world after North America, with over 500 million potential customers. According to Brightfield Group, the European CBD market will grow from €270 million in 2018 to €1.4 billion by 2023, representing a blistering 42% compound annual growth rate, making it one of the fastest-growing markets. While […]
The THC-Free, CBD derma-cosmetic brand is the first known CBD skincare line to be clinically tested and commercialized across four international markets The initial launch of Pura H&W will include seven SKUs of proprietary products that will be available through e-commerce as well as cannabis and non-cannabis specific retailers TORONTO, Dec. 22, 2021 (GLOBE NEWSWIRE) […]
NEW YORK, Dec. 21, 2021 /PRNewswire/ — Sentient Brands Holdings Inc. (OTC Markets: SNBH) (“Sentient Brands” and the “Company”), a next-level product and brand development company focused on creating beauty, wellness, and lifestyle consumer brands within the $6.5 billion luxury and prestige beauty market space, today announced its launch of a social media marketing and influencer campaign for Oeuvre Skincare (“Oeuvre”), the Company’s high-performance […]
SciSparc Announces Approval of Uplisting to The Nasdaq Capital Market
TEL AVIV, Israel, Dec. 20, 2021 /PRNewswire/ — SciSparc Ltd. (OTCQB: SPRCF) a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the “Company” or “SciSparc”), today announced that its ordinary shares have been approved for listing on The Nasdaq Capital Market (“Nasdaq”) under the symbol “SPRC”. Trading […]
Significant International Tier 1 Press Coverage on Xebra in Wake of Mexican Supreme Court Decision
VANCOUVER, BC, Dec. 20, 2021 /PRNewswire/ – Xebra Brands Ltd. (“Xebra”) (CSE: XBRA) (OTC: XBRAF) (FSE: 9YC), a cannabis company, reports that it has received significant news coverage by Mexican and international Tier 1 media, since the December 2nd announcement that it has received an injunction from the Mexican Supreme Court, granting it an outright first-mover advantage in the Mexican CBD […]
CBD Life Sciences Doubles Down on Self-Service with CBD Vending Machine & Bitcoin ATMs
CBD Life Sciences Inc. (OTC Pink: CBDL) operates a brick-and-mortar CBD store in Scottsdale, Arizona, and an online shop at LBLBioscienceInc.com. While many companies are content with these distribution channels, the company continues to innovate with new self-service machines targeting both CBD and crypto sectors. Let’s look at how these moves could pay off over […]
HempFusion Launches Project OPTIMIZE to Drive $4 Million of Annual Savings
Provides Corporate Update on Retail Wins, Including the Launch of Sagely Naturals, HempFusion and Probulin in Key US Retailers. DENVER–(BUSINESS WIRE)–HempFusion Wellness Inc. (TSX:CBD.U) (OTCQB:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness company offering premium probiotic supplements and products containing CBD, today announces Project OPTIMIZE, a new initiative approved by the board […]
Sentient Brands Holdings Inc. Launches its “Oeuvre Skincare” Luxury Product Line
NEW YORK, Dec. 8, 2021 /PRNewswire/ — Sentient Brands Holdings Inc. (OTC Markets: SNBH) (“Sentient Brands” and the “Company”), a next-level product and brand development company focused on creating beauty, wellness, and lifestyle consumer brands within the $6.5 billion luxury and prestige beauty market space, today announced its launch of Oeuvre Skincare, a high-end collection of luxury bioactive skincare products, through the Company’s […]
AlphaRoot Launches Management Liability Insurance Program Calibrated to the Cannabis Industry
AlphaRoot’s management liability insurance program bridges the gap between coverage and price point for privately-held cannabis companies. NEW YORK, Dec. 7, 2021 /PRNewswire/ — BRP Group, Inc. (“BRP Group”) (NASDAQ: BRP), an independent insurance distribution firm delivering tailored insurance solutions, is pleased to announce the launch of the AlphaRoot management liability insurance program calibrated to the cannabis, […]
Cellular Goods appoints consumer goods veteran Anna Chokina as CEO
Cellular Goods is a UK-based provider of premium consumer products based on lab-made cannabinoids The Board of Cellular Goods plc is pleased to announce the appointment of Anna Chokina as Chief Executive Officer and Director to drive the Company’s next stage of growth following the launch of its inaugural product range on 1 December 2021. Anna […]
CBD Life Sciences, Inc. (CBDL) Introduces First CBD Vending Machine at Premium Outlet Mall
SCOTTSDALE, AZ / ACCESSWIRE / December 2, 2021 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces that the company is placing its first vending machine at the premium Tanger Outlets Mall located in Glendale Arizona. CBD Life Sciences Inc. is yet again expanding and thinking outside of the […]
Yooma Wellness Announces UK Rollout of Vitality CBD Products in ASDA Stores
Yooma Wellness subsidiary, Vitality CBD Limited, now offers the most extensive CBD product range in 300 ASDA Stores in the UK TORONTO, Nov. 22, 2021 (GLOBE NEWSWIRE) — Yooma Wellness Inc. (“Yooma“) (CSE: YOOM, AQSE: YOOM), a Toronto-based vertically-integrated global wellness platform that develops and markets a portfolio of wellness brands, today announced that […]
cbdMD Extends Partnership with Spotify and Joe Rogan as Exclusive CBD Advertiser
CHARLOTTE, N.C., November 18, 2021–(BUSINESS WIRE)–cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the leading, most highly trusted and best recognized CBD companies, today announced it has signed a contract extension of their advertising partnership with Spotify (NYSE: SPOT) and the Joe Rogan Experience (JRE). The company announced that the exclusive CBD partnership will […]
HempFusion Reports Strong Q3 2021 Financial Results
Consolidated Net Revenues Increased 155% in the Quarter, and Seeing Accelerated Sales Activity in Q4 2021 DENVER–(BUSINESS WIRE)–HempFusion Wellness Inc. (TSX:CBD.U) (OTCQB:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness company offering premium probiotic supplements and products containing CBD, today reported financial results for the third quarter ended September 30, 2021. All dollar amounts […]
WestCann: A Unique Business Model with Plenty of Catalysts Ahead
The legal cannabis industry has grown from humble beginnings in the early 2000s into a multi-billion dollar global industry. In addition to THC-containing products capturing market share from the black market, CBD and other cannabinoids have exploded onto the health and wellness scene as researchers continue to uncover potential benefits. Of course, a license to […]
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
In addition to his role as Founder and CEO at MAZAKALI, Sumit is a consultant to The Arcview Group and the Managing Partner of Emerald Ventures. A frequent speaker at investment seminars, Sumit acts as a mentor to Arcview and Canopy companies and serves on the Canopy Investment committee as well as the NCIA Finance […]
Tom Zuber is Zuber Lawler & Del Duca’s Managing Partner. He has a degree with highest honors in biomedical engineering and has advised some of the most iconic companies in the world on their patent and trademark portfolios. He is at the cutting edge of cannabis patent and trademark law. He holds degrees from Harvard University and Columbia Law […]
Ovation Science Inc. is a research and development company that develops topical and transdermal consumer products including its CBD/THC cannabis formulations including ARLO CBD Beauty and InVibe® MD (“health & wellness” line), and secondly, its unique DermSafe® hand sanitizer; all made with its patented Invisicare® skin delivery technology.
BDS Analytics aims to drive the cannabis sector to thrive with well-informed decisions based on factual data. By capturing millions of transactions from dispensary point-of-sale systems we provide actionable insights based on accurate information enabling dispensaries, brands, and growers to sustain their success. Their vision is to be your indispensable source for cannabis industry data […]
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
